Elevated IL-6 levels in the CSF of acute stroke patients have been shown to correlate with infarct volume and functional outcome (40, 41), while plasma IL-6 levels obtained within the first week of stroke debut correlated with brain infarct volume, stroke severity and long-term outcome (14, 42–44). This evidence concerns the gene IL6 and stroke disorder.